Lennox International approved a new form of Long-Term Incentive Award Agreement for U.S. employees at the Vice President level and above under its 2019 Equity and Incentive Compensation Plan. The updated agreement, which covers restricted stock units, performance share units, and stock appreciation rights, includes revised vesting and exercise schedules and retirement eligibility terms.
Anteris Technologies approved contingent equity grants for CEO Wayne Paterson (1,200,000 stock options and 800,000 PSUs) and David St Denis (414,000 stock options and 485,000 PSUs). The grants are subject to stockholder approval and feature a four-year vesting schedule tied to continuous employment and performance milestones.
TuHURA Biosciences adopted the 2026 Inducement Equity Incentive Plan, reserving 5,000,000 shares of common stock for equity awards to new employees. The plan is designed to provide material inducements for new hires and was adopted without stockholder approval in accordance with Nasdaq Listing Rule 5635(c)(4).
Tevogen Inc. granted performance-based restricted stock awards to its CEO Ryan Saadi (8,000,000 shares) and CFO Kirti Desai (750,000 shares) under the 2024 Omnibus Incentive Plan. Vesting is contingent upon the company achieving a $1.0 billion aggregate revenue threshold by September 30, 2031. The grants are intended to align executive compensation with long-term growth and stockholder value creation.
TuHURA Biosciences adopted the 2026 Inducement Equity Incentive Plan, reserving 5,000,000 shares of common stock for equity awards to new employees. The plan was established under Nasdaq Listing Rule 5635(c)(4) to provide material inducements for individuals to join the company.
EagleRock Land, LLC granted performance share units (PSUs) and restricted share units (RSUs) to its CEO Greg Pipkin Jr. and CFO Neal H. Shah under its Long Term Incentive Plan. The PSUs are tied to relative and absolute total shareholder return (TSR) metrics over a performance period ending in May 2029, with a maximum payout of 250% of target.
Roadzen Inc. entered into amendments to restricted stock unit (RSU) awards for its CEO, CFO, COO, and other employees to extend their vesting dates by one year. Specifically, 5,616,550 RSUs for CEO Rohan Malhotra and 1,250,007 RSUs for COO Ankur Kamboj will now vest in September 2027, while 115,000 RSUs for CFO Jean-Noël Gallardo will vest in November 2027.
The Trade Desk granted a performance-based stock option to CEO Jeff Green, allowing him to purchase up to 7,000,000 shares of Class A Common Stock. The options vest in seven tranches tied to stock price targets ranging from $18.00 to $105.00 per share, intended to align executive incentives with long-term shareholder value. The exercise price is set at $14.97 per share, the closing price on the grant date.
The Board of Stewards, Inc. approved a standstill and additional review process for a previously contemplated recognition program involving 3,000,000 restricted stock units (RSUs) under its 2024 Equity Incentive Plan. The company clarified that no individual award agreements were ever executed and no shares were issued, correcting a prior disclosure that had characterized the program as an active issuance. Any future awards under the program will be limited to management and employees and will require further formal approval and a registration statement on Form S-8.